期刊文献+

长效甘精胰岛素与口服降糖药联合治疗对2型糖尿病血糖水平及代谢功能的影响 被引量:5

Combined treatment of long-acting insulin glargine and oral antidiabetic drugs on blood glucose level and metabolic function in type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨长效甘精胰岛素与口服降糖药联合治疗2型糖尿病的效果。方法:将86例糖尿病患者根据治疗方案不同分为对照组和观察组。对照组进行常规口服降糖药治疗,观察组在此基础上加用长效甘精胰岛素。结果:观察组患者FBG、2 h PBG、HbA_(1c)、FCP、2 h CP含量显著低于对照组,血糖控制率显著高于对照组,同时低血糖发生率明显低于对照组(P<0.05)。结论:口服降糖药联合长效胰岛素可有效控制2型糖尿病患者的血糖水平,提升血糖控制率,同时降低低血糖事件的发生率,安全性高,有助于提高患者的生活质量。 Objective:To evaluate the efficacy of long-acting insulin glargine combined with oral antidiabetic agents in the treatment of type2diabetes mellitus.Methods:86patients with diabetes were divided into the control group and the observation group according to different treatment plan.The control group were treated with oral hypoglycemic agents,and the observation group were treated with long-acting insulin.Results:The content of FBG,2h PBG,HbA1c,FCP,2h CP in the observation group were significantly lower than those in the control group;the blood glucose control rate was significantly higher than the control group;the incidence of hypoglycemia was significantly lower than that of the control group(P<0.05).Conclusion:Oral hypoglycemic drugs combined with long-acting insulin can effectively control blood glucose level in patients with type2diabetes,improve blood glucose control rate,and reduce the incidence of hypoglycemia,with high safety,and it can help to improve the quality of patients life.
作者 蒋文娟 Jiang Wenjuan(The First People's Hospital of Yibin City,Sichuan Province 644000)
出处 《中国社区医师》 2017年第23期48-49,共2页 Chinese Community Doctors
关键词 口服降糖药 长效胰岛素 2型糖尿病 血糖 C肽 Oral hypoglycemic agents Long-acting insulin Type 2 diabetes mellitus Blood sugar C peptide
  • 相关文献

参考文献5

二级参考文献102

  • 1胡仁明,杨震.胰岛β细胞功能受损是2型糖尿病致病的关键因素:遗传学研究进展的启示[J].中华糖尿病杂志,2009,1(2). 被引量:3
  • 2魏巧.用阿卡波糖联合二甲双胍治疗2型糖尿病的疗效观察[J].当代医药论丛,2014,12(5):122-123. 被引量:3
  • 3汪向东,王希林,马弘,等.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,1999.
  • 4Haffner SM,Miettinen H,Stern MP.The homeostasis model in the San Antonio heart study[J].Diabetes Care,1997,20(7):1087-1092.
  • 5Phillips DI,Clark PM,Hales CN,et al.Understanding oral glucose tolerance:comparison of glucose of insulin resistance and secretion[J].Diabet Med,1994,11(3):286-292.
  • 6Holman RR,Sanjoy KP,Bethek MA,et al.10-year follow up of intensive glucose control in type 2diabetes[J].N Engl J Med,2008,359(15):1577-1589.
  • 7Holman RR,Farmer AJ, Davies MJ,et al.Three-year efficacy of complex insulin regimens in type 2 diabetes[J].N Engl J Med,2009; 361(18):1736-1747.
  • 8Philis-Tsimikas A.Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes[J].Patient Preference and Adherence,2008,2:323-332.
  • 9Holman RR,Paul SK,Bethel MA,et al.10-year follow-up of intensive glucose control in type 2 diabetes[J].N Engl J Med,2008,359:1577-1589.
  • 10Swinnen SG,Dain MP,Aronson R,et al.A 24-Week, Randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs[J].Patient Preference and Adherence,2010,33(6):1176-1178.

共引文献48

同被引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部